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Abstract
Background: Quality of life (QOL) is an important measure in the management of Irritable Bowel Syndrome (IBS).
Controversy exists in the findings of studies evaluating QOL in IBS subtypes, and little is known about this issue in
Iranian patients. Determination of the factors affecting QOL in IBS patients may influence treatment outcomes. The
aims of this study are to: 1) compare QOL between subtypes in a sample of Iranian IBS patients, 2) determine the
factors associated with QOL in IBS.
Methods: This cross sectional study included two hundred and fifty IBS patients with the mean age (± standard
deviation) of 31.62 (± 11.93) years that were referred to outpatient gastroenterology clinic. IBS patients were
diagnosed based on Rome-3 criteria by a gastroenterologist, and then they were categorized into three subtypes
according to the predominant type of bowel habit. The “QOL specific for IBS”, “Stait-trait anxiety inventory”, and
“Beck depression inventory-2” questioners were used to evaluate QOL, anxiety, and depression symptoms,
respectively.
Results: The mean QOL scores in IBS mixed subtype (71.7 ± 25.57), constipation predominant subtype (80.28 ±
25.57), and diarrhea predominant subtype (76.43 ± 19.13) were not different. (P value: 0.05) In multivariate linear
regression analysis, anxiety symptom scores were inversely correlated with QOL scores. [Standardized beta: -0.43,
(95% confidence interval: -0.70, -0.39), P value: < 0.01]
Conclusion: It seems reasonable to manage anxiety symptoms properly in IBS patients since this might increase
their QOL.
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Background
Irritable Bowel Syndrome (IBS) is a common gastrointest-
inal disease [1]. It is associated with significant direct
health-care costs and indirect costs related to impaired
work productivity [2]. IBS patients are diagnosed based on
Rome criteria and are categorized into different subtypes
according to the predominant type of bowel habit [3].
IBS seems to have a great impact on the health related
q u a l i t yo fl i f e( Q O L )o ft h ep a t i e n t s[ 4 ] .T h eu s eo f
health related QOL assessments have come to interest
for better understanding of the biopsychosocial model
in the functional gastrointestinal disorders [5].
Controversy exists in results of previous studies about
QOL in different IBS subtypes [6-11]. This finding
might be related to differences in cultural (such as
genetic, nutritional, and socio-demographical) and psy-
chiatric co-morbidities (such as depression and general-
ized anxiety disorder) in the studied populations.
It seems reasonable to determine QOL in different IBS
subtypes, and identify the factors affecting QOL in IBS
patients, since these findings may influence treatment
outcomes. While there are substantial data on compari-
son of QOL in IBS subtypes and factors independently
associated with it in other countries, there is a paucity
of literature on this issue in Iranian patients.
According to the result of previous studies some
important variables that seemed to affect QOL in IBS
patients (such as, depression and anxiety symptoms, self
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status, geographic distribution, age, gender, and IBS sub-
type) were selected and evaluated in this study [12-14].
This study was designed to: 1) compare QOL between
IBS subtypes in a sample of Iranian patients, 2) deter-
mine the factors independently associated with QOL in
these patients.
Methods
Ethical considerations
This study was performed according to the ethical stan-
dards for human experimentation. The clinical research
committee of Kashan Shahid Beheshti Hospital approved
the study protocol (No. 6173). After explaining the aim
of the study, a written informed consent was obtained.
Patients and methods
This cross sectional study was performed on consecu-
tively selected IBS patients, older than 14 years, who
referred to outpatient gastroenterology clinic of Kashan
Shahid Beheshti Hospital between March and November
2010.
Patients with the following criteria were excluded
from the study: 1) known organic gastrointestinal dis-
eases, 2) history of abdominal trauma, surgery, or hospi-
tal admission for evaluation of abdominal pain, 3)
exacerbation of bowel symptoms with consumption of
milk or milk products, 4) alarm signs, 5) abnormal
laboratory (hematological and biochemical profiles
including thyroid function tests, anti tissue transglutami-
nase antibodies, stool exam, and urinalysis) findings, 6)
abnormal findings in barium contrast radiographies, or
in upper and lower gastrointestinal endoscopies. Alarm
signs consist of new onset of symptoms at fifty years or
older, weight loss, nocturnal diarrhea, anemia, dyspha-
gia, bloody stools, and family history of cancer [3].
Upper Gastrointestinal endoscopy and colonoscopy
with multiple duodenal and colon biopsies were per-
formed by an expert board certified gastroenterologist
for the evaluation of organic diseases including celiac
disease and microscopic colitis. Gastrointestinal diseases
were diagnosed based on the history, physical examina-
tion, laboratory data, imaging, and endoscopic studies
that were performed by the same gastroenterologist. IBS
and its subtypes were diagnosed according to Rome-3
criteria in the absence of alarm signs [3]. Those partici-
pants who were eligible for the study were included.
IBS with constipation (IBS-C) subtype was diagnosed
if hard or lumpy stools were present in more than 25%
and loose (mushy) or watery stools in less than 25% of
bowel movements. IBS with diarrhea (IBS-D) subtype
was diagnosed if hard or lumpy stools were present in
less than 25% and loose (mushy) or watery stools in
more than 25% of bowel movements. Mixed IBS (IBS-
M) subtype was diagnosed if hard or lumpy stools in
more than 25% and loose (mushy) or watery stools were
present in more than 25% of bowel movements [3].
The consistency of stool was defined according to
patient report, using Bristol form scale [15]. Hard or
lumpy stools were defined if separate hard lumps like
nuts (difficult to pass) or sausage shaped but lumpy
stools were present. Loose (mushy) or watery stools
were defined if fluffy pieces with ragged edges, a mushy
stool or watery, no solid pieces, or liquid stools were
present.
Questionnaires
Health related quality of life questionnaire
Disease specific QOL for IBS (IBS-QOL) is a thirty four-
item self-report questionnaire. This questionnaire is
especially designed to evaluate QOL in IBS patients
[16]. A five point Likert response scale (0 to 4) was used
to measure how much each statement described the
respondents’ feelings (not at all, slightly, moderately,
quite a bit, and extremely or a great deal). The question-
naire evaluated eight subscales: dysphoria, interference
with activities, body image, health worry, food avoid-
ance, social reaction, sexual function, and relationships
[16]. All items scores were summed to calculate total
scores. Higher total scores indicated better QOL.
Depression questionnaire
Presence and severity of the symptoms of depression in
participants were determined using Beck Depression
Inventory 2 [17]. This valid and reliable test is a twenty
one-item self-report questionnaire that assesses the exis-
tence and severity of symptoms of depression (for
screening and quick diagnosis) as listed in the American
Psychiatric Association’s Diagnostic and Statistical Man-
ual of Mental Disorders Forth Edition (DSM-4) in adults
and adolescence over thirteen years. The patients were
asked to consider each statement as it was related to the
way they felt in the past two weeks. Each item score
ranges from zero to three. The total score that ranges
from zero to sixty-three predicts the severity of depres-
sive symptoms. The scores ranging from 0 to 13 are
indicative of minimal depression, scores from 14 to 19
are considered to reflect a mild level of depression,
scores from 20 to 28 are presenting moderate, and a
score ranging from 29 to 63 is labeled severe [18].
Anxiety questionnaire
The presence and severity of symptoms of anxiety in
participants were determined using Spielberger State/
Trait Inventory [19]. This self-report questionnaire con-
sists of 20 items for evaluation of state anxiety and 20
items for evaluation of trait anxiety. The trait anxiety
assesses the general tendency for anxiety, while state
anxiety is a measure of anxiety experienced at time of
the test. Each item score ranges from one to four. All
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calculate total scores. The higher total scores indicated
higher levels of anxiety symptoms. The scores ranging
from 20 to 31 were indicative of mild state/trait anxiety
symptom, scores from 32 to 53 were considered to
reflect a moderate level of anxiety, and scores higher
than 54 were labeled severe [19]. We used the sum of
state and trait anxiety scores as the indicator of anxiety
symptom. Therefore, the anxiety score ranged from 40
to 160 in this study.
The Persian version of the above mentioned question-
naires were shown to be valid and reliable for use by
the previous studies in Iran [20,21]. The clinical psychia-
trist supervised the participants while they were filling
out the self-report questionnaires to ensure that they
answered all questions. The participants could ask the
clinical psychiatrist for clarifications regarding the
meaning of the questions and then filled out the ques-
tionnaires themselves.
Self-reported symptom severity questionnaire
The global assessment of symptom severity in the past
four weeks was measured using the question “How bad
is the discomfort?” where discomfort was recognized as
abdominal pain and IBS associated bowel symptoms.
Responses were graded as mild (can be overlooked if I
do not think about it), moderate (cannot be overlooked,
but does not influence my lifestyle), or severe (influ-
ences my lifestyle).
Social characteristics
Educational status was categorized as “low degree” and
“high degree” groups. The low degree group consisted
of individuals who had education up to high school. The
high degree group consisted of those who had education
more than college. Marital status was categorized as
“married” and “single” groups. The single group con-
sisted of unmarried, widows, and divorced individuals.
Geographic distribution was categorized into urban and
rural. Residents of cities (in the area of study) for the
past years were considered as the urban group. Those
living in the countryside were considered as rural.
Statistical analyses
The Kolmogorov-Smirnov test was used to evaluate the
normal distribution of the continuous variables. Com-
parison of gender, self-reported symptom severity, edu-
cational status, marital status, and geographic
distribution between IBS subtypes were performed using
chi-squared test. Comparison of mean age, depression
and anxiety symptoms, and QOL between IBS subtypes
was performed by analysis of variances (ANOVA).
The correlation between QOL and age, gender, self-
reported symptom severity, IBS subtype, educational sta-
tus, marital status, and geographic distribution, anxiety
and depression symptoms were analyzed using
multivariate linear regression analysis and standardized
beta were calculated.
The statistical analyses were performed using SPSS
v e r s i o n1 7( S P S S ,C h i c a g o ,I L ,U S A ) .T h ep r o b a b i l i t yo f
the difference between the dependent and independent
variables were considered significant if P value was less
than 0.05.
Results
Among the three hundred IBS patients visited in the
outpatient gastroenterology clinic, two hundred and fifty
patients (ranging from 14 to 61 years) with the mean (±
Standard Deviation) age of 31.62 (± 11.93) years were
eligible for participating in the study and were enrolled.
The QOL, anxiety and depression symptom scores
were normally distributed (Z = 1.3, 1.4, and 1.2 respec-
tively; all P values > 0.05).
The comparisons of mean (± Standard Deviation) age,
QOL, anxiety and depression symptom, gender, self-
reported symptom severity, educational status, marital
status, and geographic distribution between IBS subtypes
are demonstrated in table 1.
The relationship between QOL scores and age, gender,
anxiety and depression symptom, self-reported symptom
severity, educational status, marital status, geographic
distribution, and IBS type in multivariate regression ana-
lysis are demonstrated in table 2.
Discussion
Based on the results of this study, QOL was not differ-
ent between IBS subtypes. This finding is in consistence
with the results of the previous studies that used differ-
e n tf o r m so fg e n e r i ca n dd i s e a s es p e c i f i cq u e s t i o n n a i r e s
for the evaluation of QOL [7-9,11,22-24]. However, in
the study of Erikson et al QOL was lower in IBS-M and
IBS-C when compared with IBS-D [7]. Meanwhile, Si et
al reported that QOL in IBS-C is lower than IBS-D [10].
The anxiety and depression symptom mean scores
were not different among IBS subtypes in this study.
This is similar to the results of the previous studies that
used different forms of questionnaires for the evaluation
of anxiety and depression symptoms in IBS patients
[8,9,23,25]. On the other hand, Erikson et al showed
that the mean anxiety and depression scores were higher
when IBS-C and IBS-M were compared with IBS-D
using “Psychosocial Rating Scale” [7]. Meanwhile, Mus-
catello et al showed that the mean anxiety and depres-
sion scores were higher in IBS-C than IBS-D using
“Anxiety Status Index” and “Hamilton Rating Scale for
Depression” [8]. However, there was no significant dif-
ference in the mean anxiety and depression scores
between IBS-C and IBS-D in the same study when
“Hamilton Rating Scale for Anxiety” and “Montgomery-
Asberg Depression Rating Scale” was used. Cho et al
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depression symptoms than other subtypes using “Hospi-
tal Anxiety and Depression Scale” [24].
T h ec o m p a r i s o n so fQ O L ,a n x i e t ya n dd e p r e s s i o n
symptoms in IBS subtypes increase our knowledge on
the psychometric ability and clinical application of the
used instruments. The differences among the results of
above-mentioned studies on QOL, anxiety and
depression symptoms between IBS subtypes may be
related to the type of questionnaire used and cultural
differences in the studied populations. When comparing
the results of these cross sectional studies, we should
keep in mind that IBS subtypes may change into one
another if they are followed for long enough periods,
therefore comparison of these parameters between IBS
subtypes might change [9].
In this study, QOL was independently associated with
anxiety; however, age, gender, depression symptom, IBS
subtypes, symptom severity, geographic distribution,
educational, and marital status were not related to QOL.
Jerndal et al proposed that anxiety was an important
factor affecting QOL in IBS patients [26]. Kanasawa et
al found that QOL was not related to gender, IBS sub-
types, educational, and marital status [27]. Simren et al
reported that IBS subtypes did not affect QOL [28].
Another study, which used “World Health Organization
QOL-BREF” and “Bradley well-being QOL” measures,
showed that QOL was not affected by socio-demo-
graphic parameters in diabetic patients [29].
Clinical application
As the result of this study showed, QOL was inversely
correlated with anxiety symptom. Therefore, the proper
management of anxiety symptom in IBS patients may
improve their QOL.
Strengths and limitations
The strength of this study was comparison of QOL con-
sidering anxiety and depression symptoms in an accep-
table sample size of IBS patients. To recognize the IBS
patients accurately, the gastroenterologist and not a gen-
eral practitioner examined the participants. The clinical
psychiatrist supervised and assisted the participants to
complete the questionnaires precisely and completely.
One limitation of this study is evaluating just the out-
patients. This study included IBS patients who referred
to the gastroenterology clinic as an outpatient, and
Table 1 Comparison of demographic and psychosocial
characteristics between irritable bowel subtypes
IBS-M
N = 120
IBS-C
N=7 5
IBS-D
N=5 5
P
value
Age (year) 31.97 ±
13.46
32.90 ±
10.09
29.12 ±
10.42
0.18
Gender (number)
Male 60 22 39 0.35
Female 60 36 33
Quality of life 71.70 ±
25.57
80.28 ±
25.57
76.43 ±
19.13
0.05
Anxiety symptom 91.42 ±
21.23
87.92 ±
19.95
92.90 ±
13.80
0.30
Depression
symptom
14.49 ±
7.32
11.90 ±
8.39
14.25 ±
6.47
0.05
Symptom severity
Mild 54 46 22 0.07
Moderate 47 22 27
Severe 19 6 6
Educational status
Low degree 99 61 46 0.94
High degree 21 14 9
Marital status
Single 24 9 10 0.34
Married 96 66 45
Geographic
distribution
Urban 113 70 50 0.72
Rural 7 5 5
IBS, Irritable Bowel Syndrome; M, Mixed subtype; C, Constipation predominant
subtype; D, Diarrhea subtype; N, Number
Table 2 The relationship between quality of life and demographic and psychosocial characteristics in the study
population
Standardized beta 95% confidence interval for beta P value
Age 0.08 (-0.43) - (0.07) 0.15
Gender 0.01 (-5.88) - (4.53) 0.79
Anxiety symptom -0.43 (-0.70) - (-0.39) < 0.01
Depression symptom -0.06 (-0.69) - (0.29) 0.43
Symptom severity (mild versus others) -0.12 (-13.21) - (0.85) 0.09
IBS subtype (M versus others) -0.10 (-10.27) - (0.20) 0.06
Education status -0.04 (-9.87) - (4.03) 0.41
Marital status -0.00 (-8.17) - (7.66) 0.94
Geographic distribution -0.08 (-18.94) - (1.85) 0.11
IBS, Irritable Bowel Syndrome; M, Mixed subtype
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tion of abdominal pain were excluded. Therefore, the
results of this study cannot be generalized to all IBS
patients, especially those with severe symptoms who
need hospitalization for further managements and even
those with mild symptoms that do not consult a physi-
cian for their symptoms.
The use of cross sectional design is the second limita-
tion of this study, since the changes of QOL after
proper management could not be evaluated. Considering
the conversion of subtypes into one another in the nat-
ural course of disease, this cross sectional study has a
limited value for the evaluation of QOL, anxiety, and
depression symptoms in IBS subtypes [10].
Future work
Longitudinal prospective study to assess the changes of
QOL after proper management, and evaluation of fac-
tors affecting QOL in Iranian IBS subtypes including
those with severe symptoms (inpatients) and those with
mild symptoms (non-consulters in general population)
is recommended.
Conclusions
This cross sectional study conducted on a sample of Ira-
nian IBS patients referred to a secondary health care
center showed that: 1) the mean QOL, anxiety and
depression symptom scores were not different among
subtypes. 2) QOL was inversely correlated with anxiety.
Therefore, it seems reasonable to manage anxiety symp-
tom in IBS patients to increase their QOL.
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